Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
June 11, 2009
Selenoprotein P regulation by the glucocorticoid receptor
Colleen Rock, Philip J Moos
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 10, 2010
Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1
Colleen Rock, Philip J Moos
Biochemical Pharmacology
|
October 6, 2010
Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction
Robyn L Poerschke, Philip J Moos
Cancer Investigation
|
June 18, 2004
Impact of microarray technology in clinical oncology
Elizabeth A Raetz, Philip J Moos
Nanomedicine : Nanotechnology, Biology, and Medicine
|
December 6, 2017
Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles
Mostafa Yazdimamaghani, Philip J Moos, Hamidreza Ghandehari
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 23, 2019
Time- and dose-dependent gene expression analysis of macrophage response as a function of porosity of silica nanoparticles
Mostafa Yazdimamaghani, Philip J Moos, Hamidreza Ghandehari
Toxicology and Applied Pharmacology
|
September 29, 2009
Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity
Matthew Honeggar, Robert Beck, Philip J Moos
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
September 5, 2008
Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid
Robyn L Poerschke, Michael R Franklin, Philip J Moos
Plos One
|
January 26, 2010
JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1
Kornelia Edes, Pamela Cassidy, Paul J Shami, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
December 12, 2018
Genotoxicity of amorphous silica nanoparticles: Status and prospects
Mostafa Yazdimamaghani, Philip J Moos, Marina A Dobrovolskaia, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
June 11, 2009
Selenoprotein P regulation by the glucocorticoid receptor
Colleen Rock, Philip J Moos
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
September 10, 2010
Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1
Colleen Rock, Philip J Moos
Biochemical Pharmacology
|
October 6, 2010
Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction
Robyn L Poerschke, Philip J Moos
Cancer Investigation
|
June 18, 2004
Impact of microarray technology in clinical oncology
Elizabeth A Raetz, Philip J Moos
Nanomedicine : Nanotechnology, Biology, and Medicine
|
December 6, 2017
Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles
Mostafa Yazdimamaghani, Philip J Moos, Hamidreza Ghandehari
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 23, 2019
Time- and dose-dependent gene expression analysis of macrophage response as a function of porosity of silica nanoparticles
Mostafa Yazdimamaghani, Philip J Moos, Hamidreza Ghandehari
Toxicology and Applied Pharmacology
|
September 29, 2009
Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity
Matthew Honeggar, Robert Beck, Philip J Moos
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
September 5, 2008
Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid
Robyn L Poerschke, Michael R Franklin, Philip J Moos
Plos One
|
January 26, 2010
JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1
Kornelia Edes, Pamela Cassidy, Paul J Shami, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
December 12, 2018
Genotoxicity of amorphous silica nanoparticles: Status and prospects
Mostafa Yazdimamaghani, Philip J Moos, Marina A Dobrovolskaia, et al.
Page
of 6